Mergers and Acquisitions

J.M. Smucker Co. is expanding its pet-food business by buying the maker of Rachael Ray-branded dog food.

The agreement will accelerate the development of Pfizer's chimeric antigen receptor T cell (CAR T) therapy, an investigational immune cell therapy for treating cancer.

Twenty-First Century Fox said it could legally separate Sky News within the wider Sky group to allay the concerns of a British regulator about the news service's continuing independence under Rupert Murdoch's ownership.

The hospital sector has already been grappling with sluggish growth and competition from cheaper health-care options.

Among the big media conglomerates, it’s hard to find a company that isn’t contemplating a deal.

The New York Stock Exchange is in talks to buy the Chicago Stock Exchange.

Mergers and acquisitions had the strongest start ever in the 1Q.

The deal would be big: Humana currently has a market value of about $37 billion.

U.S. financial exchange operator CME is taking over London-based peer Nex in a deal that values the British company at 3.9 billion pounds ($5.4 billion).

U.S. exchange operator CME Group is buying Michael Spencer's NEX Group of the UK.

The CEO of Turner says the network pays $2 billion annually in deals with the NBA, NCAA and others.

Shares in Irish drugmaker Shire Plc are up sharply after Japanese rival Takeda said it's considering a takeover offer.

Brookfield Property Partners and GGP have reached an agreement for Brookfield to buy the remaining shares of the mall owner it doesn't already own.

Swiss pharmaceutical firm Novartis says it is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.

Novartis will sell its 36.5 percent stake in a consumer healthcare joint venture to GSK for $13.0 billion in cash.